Intimation of record date i.e. 17th April, 2026, for the E-voting process pursuant to the Extraordinary General Meeting scheduled to be held on 28th April, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Asston Pharmaceuticals Limited has announced a record date of 17th April 2026 for determining shareholder eligibility to vote at an Extraordinary General Meeting scheduled for 28th April 2026 at 12:30 PM via video conferencing. E-voting will be available from 23rd April (09:00 AM) to 27th April 2026 (05:00 PM) through NSDL. The filing does not specify what business will be transacted at the EGM, but an Extraordinary General Meeting typically indicates urgent or significant matters requiring shareholder approval that cannot wait for the next Annual General Meeting.
Shareholders holding shares as of 17th April 2026 will be eligible to participate and vote. The actual stock impact will depend on what resolutions are passed at the EGM, which has not been disclosed in this filing. Investors should monitor for subsequent filings detailing the EGM agenda.